In ARID1A-inactivated ovarian carcinoma clear cell carcinoma (OCCC), the loss of ARID1A increases glutamine utilization and metabolism through upregulation of the expression of glutaminase (GLS1), a key enzyme in glutamine metabolism that is overexpressed in several human cancers. Here, ARID1A is linked to cancer.